Previous research demonstrated that humanized liver chimeric mice derived from albumin enhancer/promoter-driven cDNA of urokinase-type plasminogen activator/severe combined immunodeficiency (cDNA-uPA/SCID) mice maintained stable human hepatocyte populations for several months [17]. This evidence concerns the gene PLAU and severe combined immunodeficiency.